Back to companies
Kymera Therapeutics, Inc.
KYMRUSNASDAQPharmaceuticals & HealthcareKymera Therapeutics, Inc.
Revenue
$39.2mn
YoY -16.7%
Operating income
-$349.4mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API